These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 29213125)

  • 21. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 23. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
    Zinger H; Sherer Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inflammatory rheumatism within the framework of autoimmune diseases].
    Van Slype J
    J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
    [No Abstract]   [Full Text] [Related]  

  • 25. Semaphorins 4A and 4D in chronic inflammatory diseases.
    Chapoval SP; Vadasz Z; Chapoval AI; Toubi E
    Inflamm Res; 2017 Feb; 66(2):111-117. PubMed ID: 27554682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemopoietic stem cell transplantation in rheumatic diseases--an update.
    de Buys P; Khanna D; Furst DE
    Autoimmun Rev; 2005 Sep; 4(7):442-9. PubMed ID: 16137610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D and autoimmune rheumatic diseases.
    Cutolo M
    Rheumatology (Oxford); 2009 Mar; 48(3):210-2. PubMed ID: 18930963
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
    J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropilins and semaphorins - from angiogenesis to autoimmunity.
    Vadasz Z; Attias D; Kessel A; Toubi E
    Autoimmun Rev; 2010 Oct; 9(12):825-9. PubMed ID: 20678594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris.
    Mavropoulos A; Orfanidou T; Liaskos C; Smyk DS; Billinis C; Blank M; Rigopoulou EI; Bogdanos DP
    Autoimmun Rev; 2013 Mar; 12(5):580-90. PubMed ID: 23207287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus.
    Tyndall A
    J Rheumatol Suppl; 1997 May; 48():94-7. PubMed ID: 9150127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
    Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
    Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in rheumatic autoimmune diseases.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases.
    Sakkas LI; Daoussis D; Mavropoulos A; Liossis SN; Bogdanos DP
    Semin Arthritis Rheum; 2019 Jun; 48(6):1133-1141. PubMed ID: 30409417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity.
    Bogdanos DP; Smyk DS; Rigopoulou EI; Sakkas LI; Shoenfeld Y
    Lupus; 2015 Apr; 24(4-5):364-73. PubMed ID: 25801879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.
    Wu H; Chen Y; Zhu H; Zhao M; Lu Q
    Front Immunol; 2019; 10():2305. PubMed ID: 31611879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma-exchange in the treatment of systemic rheumatic diseases: past and present experience].
    Cozzi F; Marson P
    Reumatismo; 2009; 61(3):161-4. PubMed ID: 19888500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.